,

Abhimanu Pandey1, Shweta Venkataraman1, Si Ming Man2

  • 1Division of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia; Haematology Translational Research Unit, ACT Pathology, Canberra Health Services, Canberra, ACT 2605, Australia.

STAR protocols
|September 28, 2024
PubMed
概括

本协议详细说明了血液和骨髓等患者样本的生物银行,用于血液恶性瘤. 它可以在翻译研究中进行多组学分析,以获得血液癌症的见解和治疗化合物的测试.